As the understanding of how ATRX influences aggressivity in MYCN non-amplified neuroblastoma is similar to that found in MYCN amplified neuroblastoma,10,11 an important aspect of this will be to explore therapeutic vulnerabilities in patients with ATRX mutation and ATRX loss protein. The gene discussed is MYCN; the disease is neuroblastoma.